These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 20546454)
1. Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites. Wang GP; Guan YS; Jin XR; Jiang SS; Lu ZJ; Wu Y; Li Y; Li M; Luo F J Gastroenterol Hepatol; 2010 May; 25(5):985-90. PubMed ID: 20546454 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice. Jin Y; Li J; Rong LF; Lü XW; Huang Y; Xu SY Acta Pharmacol Sin; 2005 Feb; 26(2):250-6. PubMed ID: 15663907 [TBL] [Abstract][Full Text] [Related]
3. A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity. Bocci G; Barbara C; Vannozzi F; Di Paolo A; Melosi A; Barsanti G; Allegrini G; Falcone A; Del Tacca M; Danesi R Clin Pharmacol Ther; 2006 Oct; 80(4):384-95. PubMed ID: 17015056 [TBL] [Abstract][Full Text] [Related]
4. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study. Chandrashekar NS; Shobha Rani RH J BUON; 2007; 12(4):529-34. PubMed ID: 18067212 [TBL] [Abstract][Full Text] [Related]
5. Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 may be effective against peritoneal dissemination in gastric cancer. Yamagata S; Nakata B; Hirakawa K Oncol Rep; 2004 Nov; 12(5):973-8. PubMed ID: 15492780 [TBL] [Abstract][Full Text] [Related]
6. Effect of carcinomatosis and intraperitoneal 5-fluorouracil on peritoneal blood flow modulated by vasopressin in the rat as measured with the 133Xe-clearance technique. Oman M; Tölli J; Naredi P; Hafström LO Cancer Chemother Pharmacol; 2004 Sep; 54(3):213-8. PubMed ID: 15138707 [TBL] [Abstract][Full Text] [Related]
7. Intra-aortal therapy with 5-fluorouracil- polyethylene glycol stealth liposomes: does the metabolism of 5-fluorouracil into 5-fluoro-2'-deoxyuridine depend on ph value?. An animal study in VX-2 liver tumor-bearing rabbits. Pohlen U; Binnenhei M; Reszka R; Buhr HJ; Berger G Chemotherapy; 2004 Jun; 50(2):67-75. PubMed ID: 15211080 [TBL] [Abstract][Full Text] [Related]
8. [Experimental study on 5-FU intraperitoneal injection for liver metastasis]. Kawahara H; Hirai K; Aoki T Gan To Kagaku Ryoho; 1998 May; 25(6):881-5. PubMed ID: 9617327 [TBL] [Abstract][Full Text] [Related]
9. Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits. Pohlen U; Reszka R; Schneider P; Buhr HJ; Berger G Anticancer Res; 2004; 24(3a):1699-704. PubMed ID: 15274343 [TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients. Bocci G; Danesi R; Di Paolo AD; Innocenti F; Allegrini G; Falcone A; Melosi A; Battistoni M; Barsanti G; Conte PF; Del Tacca M Clin Cancer Res; 2000 Aug; 6(8):3032-7. PubMed ID: 10955781 [TBL] [Abstract][Full Text] [Related]
11. [Drug distribution in gastric cancer and adjacent tissues by preoperative intraperitoneal chemotherapy with Co-fluorouracil liposome]. Li Y; Liu BW; DU WL; Song ZC; Zhao Q; Fan LQ; Yang JQ; Li QJ; Wang MX; Jiao ZK; Zhang ZD Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):638-40. PubMed ID: 15634532 [TBL] [Abstract][Full Text] [Related]
12. Comparison of 5-fluorouracil pharmacokinetics in whole blood, plasma, and red blood cells in patients with colorectal cancer. Wattanatorn W; McLeod HL; Macklon F; Reid M; Kendle KE; Cassidy J Pharmacotherapy; 1997; 17(5):881-6. PubMed ID: 9324177 [TBL] [Abstract][Full Text] [Related]
13. Organ distribution of 5-fluorouracil loaded gelatine microspheres in mice. Hao X; Cheng G; Zou M; Sun J; Cui F Pharmazie; 2004 Sep; 59(9):709-12. PubMed ID: 15497754 [TBL] [Abstract][Full Text] [Related]
14. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil. Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123 [TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal 5-fluorouracil infusion for treatment of both peritoneal and liver micrometastases. Archer S; Gray B Surgery; 1990 Sep; 108(3):502-7. PubMed ID: 2396194 [TBL] [Abstract][Full Text] [Related]
16. Potent antitumor effect of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine on peritoneal dissemination models of gastrointestinal cancers. Miura S; Endo Y; Yoshimura Y; Endo M; Yonemura Y; Sasaki T Oncol Rep; 2002; 9(6):1319-22. PubMed ID: 12375041 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of 5-fluorouracil and cyclophosphamide in depression rats. Duan JJ; Zhou T; Chen X; Wang Y; Wen YG; Xu F Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):427-36. PubMed ID: 22696869 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of 5-fluorouracil and its penetration into pancreatic juice in dogs. Zhu Z; Fu Q; Nightingale CH; Zhao YP; Liao Q; Wang HN; Xue CQ; Yang ZY; Li DK Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):7-9. PubMed ID: 10375748 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics following intraperitoneal sequential administration of cisplatin and fluorouracil for gastric cancer]. Hiratsuka M; Furukawa H; Iwanaga T; Nakamori S; Masutani S; Ohigashi H; Kameyama M; Sasaki Y; Kabuto T; Ishikawa O Gan To Kagaku Ryoho; 1993 Aug; 20(11):1627-30. PubMed ID: 8373234 [TBL] [Abstract][Full Text] [Related]
20. [Experimental study on intraperitoneal sequential MTX/5-FU therapy for peritoneal seeding in comparison with intravenous administration]. Maruyama M; Takamatsu S; Sugano N; Ebuchi M; Endo M; Yuasa Y Gan To Kagaku Ryoho; 1997 Nov; 24(14):2131-6. PubMed ID: 9388524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]